These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8679174)

  • 1. [Use of the economic evaluation in the comparison of different vaccination programs against Haemophilus influenzae type b disease].
    de Campora E; Pizzuti R
    Ann Ig; 1995; 7(5):329-38. PubMed ID: 8679174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
    Broughton EI
    J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine.
    Bärnighausen T; Bloom DE; Canning D; Friedman A; Levine OS; O'Brien J; Privor-Dumm L; Walker D
    Vaccine; 2011 Mar; 29(13):2371-80. PubMed ID: 21159324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida.
    Midani S; Ayoub EM; Rathore MH
    J Fla Med Assoc; 1995 Jun; 82(6):401-2. PubMed ID: 7643054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae type b diseases in Asia.
    Lau YL
    Bull World Health Organ; 1999; 77(11):867-8. PubMed ID: 10612880
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemophilus influenzae type b disease: prospects for prevention in New Zealand.
    Ameratunga SN; Lennon DR; Martin D
    N Z Med J; 1994 May; 107(978):193-4. PubMed ID: 8196862
    [No Abstract]   [Full Text] [Related]  

  • 10. [Haemophilus influenzae serotype b invasive disease].
    Campos J
    Med Clin (Barc); 1999 Jan; 112(1):16-7. PubMed ID: 10027180
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain.
    Díez-Domingo J; Pereiró I; Morant A; Gimeno C; San-Martín M; González A;
    J Infect; 2001 May; 42(4):257-60. PubMed ID: 11545568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].
    Conyn-van Spaendonck MA; Veldhuijzen IK; Suijkerbuijk AW; Hirasing RA
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1069-73. PubMed ID: 10850110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia.
    Peltola H; Aavitsland P; Hansen KG; Jónsdóttir KE; Nøkleby H; Romanus V
    J Infect Dis; 1999 Jan; 179(1):223-9. PubMed ID: 9841843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
    Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
    Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of new vaccines in immunization programs.
    Koplan JP
    Isr J Med Sci; 1986; 22(3-4):272-6. PubMed ID: 2943694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.
    Garpenholt O; Silfverdal SA; Levin LA
    Scand J Infect Dis; 1998; 30(1):5-10. PubMed ID: 9670351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of immunization on Haemophilus influenzae type b disease.
    Madore DV
    Infect Agents Dis; 1996 Jan; 5(1):8-20. PubMed ID: 8789595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Haemophilus influenzae type b invasive disease in New York State, 1987 to 1991: the role of vaccination requirements for day-care attendance.
    Schulte EE; Birkhead GS; Kondracki SF; Morse DL
    Pediatrics; 1994 Dec; 94(6 Pt 2):1014-6. PubMed ID: 7971041
    [No Abstract]   [Full Text] [Related]  

  • 19. An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease.
    McIntyre P; Hall J; Leeder S
    Aust J Public Health; 1994 Dec; 18(4):394-400. PubMed ID: 7718653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs and benefits of a vaccination programme for Haemophilus influenzae type B disease.
    Hussey GD; Lasser ML; Reekie WD
    S Afr Med J; 1995 Jan; 85(1):20-5. PubMed ID: 7784909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.